{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:46:20Z","timestamp":1790905580432,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10822-020-00306-0","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:02:27Z","timestamp":1584428547000},"page":"897-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Characterization of PD-L1 binding sites by a combined FMO\/GRID-DRY approach"],"prefix":"10.1007","volume":"34","author":[{"given":"Roberto","family":"Paciotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Agamennone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loriano","family":"Storchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"306_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252\u2013264","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"306_CR2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","volume":"37","author":"KM Mahoney","year":"2015","unstructured":"Mahoney KM, Freeman GJ, McDermott DF (2015) The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma, PD-1\/PD-L1 inhibitors. Clin Ther 37(4):764\u2013782","journal-title":"Clin Ther"},{"key":"306_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","volume":"54","author":"C Blank","year":"2005","unstructured":"Blank C, Gajewski TF, Mackensen A (2005) Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother 54:307\u2013314","journal-title":"Cancer Immunol Immunother"},{"key":"306_CR4","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/S1470-2045(14)71129-5","volume":"16","author":"E Wilkinson","year":"2015","unstructured":"Wilkinson E (2015) Nivolumab success in untreated metastatic melanoma. Lancet Oncol 16:e9","journal-title":"Lancet Oncol"},{"key":"306_CR5","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S1470-2045(14)70348-1","volume":"15","author":"S Bagcchi","year":"2014","unstructured":"Bagcchi S (2014) Pembrolizumab for treatment of refractory melanoma. Lancet Oncol 15:e419","journal-title":"Lancet Oncol"},{"key":"306_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.seminoncol.2015.05.013","volume":"42","author":"EJ Lipson","year":"2015","unstructured":"Lipson EJ, Forde PM, Hammers H, Emens LA, Taube JM, Topolian SL (2015) Antagonists of PD-1 and PD-L1 in cancer treatment. Semin Oncol 42:587\u2013600","journal-title":"Semin Oncol"},{"key":"306_CR7","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 99:12293\u201312297","journal-title":"Proc Natl Acad Sci USA"},{"key":"306_CR8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","volume":"515","author":"RS Herbst","year":"2014","unstructured":"Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS (2014) Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515:563\u2013567","journal-title":"Nature"},{"key":"306_CR9","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQM, Hwu W, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot CH, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455\u20132465","journal-title":"N Engl J Med"},{"key":"306_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/intimm\/dxu095","volume":"27","author":"GK Philips","year":"2015","unstructured":"Philips GK, Atkins M (2015) Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies. Int Immunol 27:39\u201346","journal-title":"Int Immunol"},{"key":"306_CR11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","volume":"26","author":"J Naidoo","year":"2015","unstructured":"Naidoo J, Page DB, Li BT, Connell LC, Schindler K, Lacouture ME, Postow MA, Wolchok JD (2015) Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 26:2375\u20132391","journal-title":"Ann Oncol"},{"key":"306_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2018.10.044","volume":"161","author":"T Chen","year":"2019","unstructured":"Chen T, Li Q, Liu Z, Chen Y, Feng F, Sun H (2019) Peptide based and small synthetic molecule inhibitors on PD\/PD-L1 pathway: a new choice for immunotherapy? Eur J Med Chem 161:378\u2013398","journal-title":"Eur J Med Chem"},{"issue":"6","key":"306_CR13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2016.04.011","volume":"21","author":"M Zhan","year":"2016","unstructured":"Zhan M, Hu X, Liu X, Ruan B, Xu J, Liao C (2016) From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1\/PD-L1 pathway. Drug Discovery Today 21(6):1027\u20131036","journal-title":"Drug Discovery Today"},{"key":"306_CR14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355","journal-title":"Science"},{"key":"306_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/joim.12708","volume":"283","author":"PS Chowdhury","year":"2018","unstructured":"Chowdhury PS, Chamoto K, Honjo T (2018) Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy. J Intern Med 283:110\u2013120","journal-title":"J Intern Med"},{"key":"306_CR16","unstructured":"Chupak LS, Zheng X (2015) Compounds useful as immunomodulators. WO2015034820A1"},{"key":"306_CR17","unstructured":"Chupak LS, Ding M, Martin SW, Zheng X, Hewawasam P, Connolly TP, Xu N, Yeung K-S, Zhu J, Langley DR, Tenney DJ, Scola PM, Mingo PA (2015) Compounds useful as immunomodulators. WO2015160641"},{"key":"306_CR18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1021\/acsmedchemlett.5b00148","volume":"6","author":"AF Abdel-Magid","year":"2015","unstructured":"Abdel-Magid AF (2015) Inhibitors of the PD-1\/PD-L1 pathway can mobilize the immune system: an innovative potential therapy for cancer and chronic infections. ACS Med Chem Lett 6:489\u2013490","journal-title":"ACS Med Chem Lett"},{"key":"306_CR19","doi-asserted-by":"crossref","first-page":"30323","DOI":"10.18632\/oncotarget.8730","volume":"7","author":"KM Zak","year":"2016","unstructured":"Zak KM, Grudnik P, Guzik K, Zieba BJ, Musielak B, D\u00f6mling A, Dubin G, Holak TA (2016) Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1). Oncotarget 7:30323\u201330335","journal-title":"Oncotarget"},{"issue":"77","key":"306_CR20","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1021\/acs.jmedchem.7b00293","volume":"60","author":"K Guzik","year":"2017","unstructured":"Guzik K, Zak KM, Grudnik P, Magiera K, Musielak B, T\u00f6rner R, Skalniak L, D\u00f6mling A, Dubin G, Holak TA (2017) Small-molecule inhibitors of the programmed cell death-1\/programmed death-ligand 1 (PD-1\/PD-L1) interaction via transiently induced protein states and dimerization of PD-L1. J Med Chem 60(77):5857\u20135867","journal-title":"J Med Chem"},{"key":"306_CR21","doi-asserted-by":"crossref","first-page":"72167","DOI":"10.18632\/oncotarget.20050","volume":"8","author":"L Skalniak","year":"2017","unstructured":"Skalniak L, Zak KM, Guzik K, Magiera K, Musielak B, Pachota M, Szelazek B, Kocik J, Grudnik P, Tomala M, Krzanik S, Pyrc K, D\u00f6mling A, Dubin G, Holak T (2017) A small-molecule inhibitors of PD-1\/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. Oncotarget 8:72167\u201372181","journal-title":"Oncotarget"},{"key":"306_CR22","unstructured":"Sasikumar PGN, Ramachandra M, Naremaddepalli SSS (2015) 1,2,4-Oxadiazole derivatives as immunomodulators. US20150073024"},{"key":"306_CR23","unstructured":"Sasikumar PGN, Ramachandra M, Vadlamani SK, Vemula KR, Satyam LK, Subbarao K, Shrimali RK, Kandepu S (2013) Immunosuppression modulating compounds. EP2585099A2"},{"key":"306_CR24","unstructured":"Sasikumar PGN, Ramachandra M, Naremaddepalli SSS (2013) Peptidomimetic compounds as immunomodulators. WO2013132317A8"},{"key":"306_CR25","unstructured":"Shrimali KR, Subbarao K (2012) Therapeutic compounds for immunomodulation. WO2012168944A1"},{"key":"306_CR26","unstructured":"Miller MM, Mapelli C, Allen MP, Bowsher MS, Boy KM, Gillis EP, Langley DR, Mull E, Poirier MA, Sanghvi N (2014) Macrocyclic inhibitors of the pd-1\/pd-l1 and cd80(b7-1)\/pd-l1 protein\/protein interactions. WO2014151634A1"},{"key":"306_CR27","unstructured":"Sasikumar PGN, Ramachandra M, Naremaddepalli SSS (2015) Cyclic peptidomimetic compounds as immunomodulators. WO2015033303A1"},{"key":"306_CR28","doi-asserted-by":"crossref","first-page":"13732","DOI":"10.1002\/anie.201707707","volume":"56","author":"K Magiera-Mularz","year":"2017","unstructured":"Magiera-Mularz K, Skalniak L, Zak KM, Musielak B, Rudzinska-Szostak E, Berlicki \u0141, Kocik J, Grudnik P, Sala D, Zarganes-Tzitzikas T, Shaabani S, D\u00f6mling A, Dubin G, Holak TA (2017) Bioactive macrocyclic inhibitors of the PD-1\/PD-L1 immune checkpoint. Angew Chemie Int Ed 56:13732\u201313735","journal-title":"Angew Chemie Int Ed"},{"key":"306_CR29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cmdc.201500566","volume":"11","author":"H Weinmann","year":"2016","unstructured":"Weinmann H (2016) Cancer immunotherapy: selected targets and small-molecule modulators. ChemMedChem 11:450\u2013466","journal-title":"ChemMedChem"},{"key":"306_CR30","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3390\/molecules24112071","volume":"24","author":"K Guzik","year":"2019","unstructured":"Guzik K, Tomala M, Muszak D, Konieczny M, Hec A, B\u0142aszkiewicz U, Pustu\u0142a M, Butera R, D\u00f6mling A, Holak TA (2019) Development of the inhibitors that target the PD-1\/PD-L1 interaction\u2014a brief look at progress on small molecules, peptides and macrocycles. Molecules 24:2071","journal-title":"Molecules"},{"key":"306_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein\u2013protein interfaces. Nature 450:1001\u20131009","journal-title":"Nature"},{"key":"306_CR32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd1343","volume":"3","author":"RM Arkin","year":"2004","unstructured":"Arkin RM, Wells JA (2004) Small-molecule inhibitors of protein\u2013protein interactions: progressing towards the dream. Nat Rev Drug Discovery 3:301","journal-title":"Nat Rev Drug Discovery"},{"key":"306_CR33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/bip.20608","volume":"84","author":"DC Fry","year":"2006","unstructured":"Fry DC (2006) Protein\u2013protein interactions as targets for small molecule drug discovery. Biopolymers 84:535\u2013552","journal-title":"Biopolymers"},{"key":"306_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmbi.1998.1843","volume":"280","author":"AA Bogan","year":"1998","unstructured":"Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280:1\u20139","journal-title":"J Mol Biol"},{"issue":"6","key":"306_CR35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/bioinformatics\/btp058","volume":"25","author":"J Li","year":"2009","unstructured":"Li J, Liu Q (2009) \u2018Double water exclusion\u2019: a hypothesis refining the O-ring theory for the hot spots at protein interfaces. Bioinformatics 25(6):743\u2013750","journal-title":"Bioinformatics"},{"key":"306_CR36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/prot.21396","volume":"68","author":"IS Moreira","year":"2007","unstructured":"Moreira IS, Fernandes PA, Ramos MJ (2007) Hot spots\u2014a review of the protein\u2013protein interface determinant amino-acid residues. Proteins 68:803\u2013812","journal-title":"Proteins"},{"issue":"22","key":"306_CR37","doi-asserted-by":"crossref","first-page":"14116","DOI":"10.1073\/pnas.202485799","volume":"99","author":"T Kortemme","year":"2002","unstructured":"Kortemme T, Baker D (2002) A simple physical model for binding energy hot spots in protein\u2013protein complexes. PNAS 99(22):14116\u201314121","journal-title":"PNAS"},{"issue":"9","key":"306_CR38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138161212799436412","volume":"18","author":"JK Morrow","year":"2012","unstructured":"Morrow JK, Zhang S (2012) Computational prediction of hot spot residues. Curr Pharm Des 18(9):1255\u20131265","journal-title":"Curr Pharm Des"},{"issue":"3","key":"306_CR39","doi-asserted-by":"crossref","first-page":"e32839","DOI":"10.1371\/journal.pone.0032839","volume":"7","author":"D Koes","year":"2012","unstructured":"Koes D, Khoury K, Huang Y, Wang W, Bista M, Popowicz GM, Wolf S, Holak TA, D\u00f6mling A, Camacho CJ (2012) Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists. PlosOne 7(3):e32839","journal-title":"PlosOne"},{"issue":"8","key":"306_CR40","doi-asserted-by":"crossref","first-page":"e12352","DOI":"10.1371\/journal.pone.0012352","volume":"5","author":"JS Mora","year":"2010","unstructured":"Mora JS, Assi SA, Fernandez-Fuentes N (2010) Presaging critical residues in protein interfaces-web server (PCRPi-W): a web server to chart hot spots in protein interfaces. PlosOne 5(8):e12352","journal-title":"PlosOne"},{"key":"306_CR41","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1039\/c2cp23784a","volume":"14","author":"DG Fedorov","year":"2012","unstructured":"Fedorov DG, Nagata T, Kitaura K (2012) Exploring chemistry with the fragment molecular orbital method. Phys Chem Chem Phys 14:7562\u20137577","journal-title":"Phys Chem Chem Phys"},{"key":"306_CR42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0009-2614(99)00874-X","volume":"313","author":"K Kitaura","year":"1999","unstructured":"Kitaura K, Ikeo E, Asada T, Nakano T, Uebayasi M (1999) Fragment molecular orbital method: an approximate computational method for large molecules. Chem Phys Lett 313:701\u2013706","journal-title":"Chem Phys Lett"},{"key":"306_CR43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0009-2614(00)00070-1","volume":"318","author":"T Nakano","year":"2000","unstructured":"Nakano T, Kaminuma T, Sato T, Akiyama Y, Uebayasi M, Kitaur K (2000) Fragment molecular orbital method: application to polypeptides. Chem Phys Lett 318:614\u2013618","journal-title":"Chem Phys Lett"},{"key":"306_CR44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmgm.2009.04.001","volume":"28","author":"K Nagase","year":"2009","unstructured":"Nagase K, Kobayashi H, Yoshikawa E, Kurita N (2009) Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor. J Mol Graphics Modell 28:46\u201353","journal-title":"J Mol Graphics Modell"},{"key":"306_CR45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/prot.25621","volume":"87","author":"R Paciotti","year":"2019","unstructured":"Paciotti R, Storchi L, Marrone A (2019) An insight of early PrP-E200K aggregation by combined molecular dynamics\/fragment molecular orbital approaches. Proteins 87:51\u201361","journal-title":"Proteins"},{"key":"306_CR46","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/prot.24836","volume":"83","author":"L Storchi","year":"2015","unstructured":"Storchi L, Paciotti R, Re N, Marrone A (2015) Investigation of the molecular similarity in closely related protein systems: the PrP case study. Proteins 83:1751\u20131765","journal-title":"Proteins"},{"key":"306_CR47","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jcc.20399","volume":"27","author":"K Fukuzawa","year":"2006","unstructured":"Fukuzawa K, Komeiji Y, Mochizuki Y, Kato A, Nakano T, Tanaka S (2006) Intra- and intermolecular interactions between cyclic-AMP receptor protein and DNA: ab initio fragment molecular orbital study. J Comput Chem 27:948\u2013960","journal-title":"J Comput Chem"},{"key":"306_CR48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.compbiolchem.2005.09.005","volume":"29","author":"T Nemoto","year":"2005","unstructured":"Nemoto T, Fedorov DG, Uebayasi M, Kanazawa K, Kitaura K, Komeiji Y (2005) Ab initio fragment molecular orbital (FMO) method applied to analysis of the ligand\u2013protein interaction in a pheromone-binding protein. Comput Biol Chem 29:434\u2013439","journal-title":"Comput Biol Chem"},{"issue":"3","key":"306_CR49","first-page":"423A","volume":"114","author":"HC Lim","year":"2018","unstructured":"Lim HC, Chun JH, Hwang SB, Kim JW, No KT (2018) Specific interactions of protein-protein interaction between human programmed death 1 (PD-1) and its ligand 1 (PD-L1) with ab initio fragment molecular orbital method. Biophys J 114(3):423A","journal-title":"Biophys J"},{"key":"306_CR50","doi-asserted-by":"crossref","first-page":"16727","DOI":"10.1038\/s41598-019-53216-z","volume":"9","author":"H Lim","year":"2019","unstructured":"Lim H, Chun J, Jin X, Kim J, Yoon JH, No KT (2019) Investigation of protein-protein interactions and hot spot region between PD-1 and PD-L1 by fragment molecular orbital method. Sci Rep 9:16727","journal-title":"Sci Rep"},{"key":"306_CR51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","volume":"28","author":"PJ Goodford","year":"1985","unstructured":"Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849\u2013857","journal-title":"J Med Chem"},{"key":"306_CR52","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.str.2015.09.010","volume":"23","author":"KM Zak","year":"2015","unstructured":"Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, D\u00f6mling A, Dubin G, Holak TA (2015) Structure of the complex of human programmed death 1, PD-1, and its ligand PD-L1. Structure 23:2341\u20132348","journal-title":"Structure"},{"issue":"3","key":"306_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mol Des 27(3):221\u2013234","journal-title":"J Comput Aid Mol Des"},{"key":"306_CR54","unstructured":"Schr\u00f6dinger Release 2018\u20133: Schr\u00f6dinger Suite 2018\u20133 Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2016 Impact, Schr\u00f6dinger, LLC, New York, NY, 2016; Prime, Schr\u00f6dinger, LLC, New York, NY, 2018; Schr\u00f6dinger Release 2018\u20133: Prime, Schr\u00f6dinger, LLC, New York, NY, 2018; Schr\u00f6dinger Release 2018\u20133: MacroModel, Schr\u00f6dinger, LLC, New York, NY, 2018; Schr\u00f6dinger Release 2018\u20133: LigPrep Schr\u00f6dinger LLC, New York, NY (2018)"},{"key":"306_CR55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJF, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55:351\u2013367","journal-title":"Proteins"},{"key":"306_CR56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson MP, Friesner RA, Xiang Z, Honig B (2002) On the role of crystal packing forces in determining protein side chain conformations. J Mol Biol 320:597\u2013608","journal-title":"J Mol Biol"},{"key":"306_CR57","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jcc.540141112","volume":"14","author":"MW Schmidt","year":"1993","unstructured":"Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JH, Koseki S, Matsunaga N, Nguyen KA, Su S, Windus TL, Dupuis M, Montgomery JA (1993) General atomic and molecular electronic structure system. J Comput Chem 14:1347\u20131363","journal-title":"J Comput Chem"},{"key":"306_CR58","unstructured":"Gordon MS, Schmidt MW (2005) In: Dykstra CE, Frenking G, Kim KS, Scuseria GE (eds) Theory and applications of computational chemistry: the first forty years. Elsevier, Amsterdam, pp 1167\u20131189"},{"key":"306_CR59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cplett.2009.04.045","volume":"474","author":"T Ishikawa","year":"2009","unstructured":"Ishikawa T, Kuwata K, Ishikawa T, Kuwata K (2009) Fragment molecular orbital calculation using the RI-MP2 method. Chem Phys Lett 474:195\u2013198","journal-title":"Chem Phys Lett"},{"key":"306_CR60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/jz201697x","volume":"3","author":"T Ishikawa","year":"2012","unstructured":"Ishikawa T, Kuwata K (2012) RI-MP2 gradient calculation of large molecules using the fragment molecular orbital method. J Phys Chem Lett 3:375\u2013379","journal-title":"J Phys Chem Lett"},{"key":"306_CR61","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/cr9904009","volume":"105","author":"J Tomasi","year":"2005","unstructured":"Tomasi J, Mennucci B, Cammi R (2005) Quantum mechanical continuum solvation models. Chem Rev 105:2999\u20133093","journal-title":"Chem Rev"},{"key":"306_CR62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jcc.20406","volume":"27","author":"DG Fedorov","year":"2006","unstructured":"Fedorov DG, Kitaura K, Li H, Jensen JH, Gordon MS (2006) The polarizable continuum model (PCM) interfaced with the fragment molecular orbital method (FMO). J Comput Chem 27:976\u2013985","journal-title":"J Comput Chem"},{"key":"306_CR63","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcc.21363","volume":"31","author":"H Li","year":"2010","unstructured":"Li H, Fedorov DG, Nagata T, Kitaura K, Jensen JH, Gordon MS (2010) Energy gradients in combined fragment molecular orbital and polarizable continuum model (FMO\/PCM) calculation. J Comput Chem 31:778\u2013790","journal-title":"J Comput Chem"},{"key":"306_CR64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jcc.20496","volume":"28","author":"DG Fedorov","year":"2007","unstructured":"Fedorov DG, Kitaura K (2007) Pair interaction energy decomposition analysis. J Comput Chem 28:222\u2013237","journal-title":"J Comput Chem"},{"key":"306_CR65","doi-asserted-by":"crossref","first-page":"10310","DOI":"10.1039\/C4CP00316K","volume":"16","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Mochizuki Y, Komeiji Y, Okiyama Y, Fukuzawa K (2014) Electron-correlated fragment-molecular-orbital calculations for biomolecular and nano systems. Phys Chem Chem Phys 16:10310\u201310344","journal-title":"Phys Chem Chem Phys"},{"key":"306_CR66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jmgm.2017.02.013","volume":"74","author":"M Ozawa","year":"2017","unstructured":"Ozawa M, Ozawa T, Ueda K (2017) Application of the fragment molecular orbital method analysis to fragment-based drug discovery of BET (bromodomain and extra-terminal proteins) inhibitors. J Mol Graphics Modell 74:73\u201382","journal-title":"J Mol Graphics Modell"},{"key":"306_CR67","unstructured":"https:\/\/www.moldiscovery.com\/soft_grid.php. Accessed February 2019"},{"key":"306_CR68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M Von Itzstein","year":"1993","unstructured":"Von Itzstein M, Wu W, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418\u2013423","journal-title":"Nature"},{"key":"306_CR69","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/ci700018y","volume":"47","author":"F Milletti","year":"2007","unstructured":"Milletti F, Storchi L, Sforna G, Cruciani G (2007) New and original pKa prediction method using grid molecular interaction fields. J Chem Inf Model 47:2172\u20132181","journal-title":"J Chem Inf Model"},{"key":"306_CR70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1021\/ci800340j","volume":"49","author":"F Milletti","year":"2009","unstructured":"Milletti F, Storchi L, Sforna G, Cross S, Cruciani G (2009) Tautomer enumeration and stability prediction for virtual screening on large chemical databases. J Chem Inf Model 49:68\u201375","journal-title":"J Chem Inf Model"},{"key":"306_CR71","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/ci049626p","volume":"45","author":"MM Ahlstrom","year":"2005","unstructured":"Ahlstrom MM, Ridderstr\u00f6 M, Luthman K, Zamora I (2005) Virtual screening and scaffold hopping based on GRID molecular interaction fields. J Chem Inf Model 45:1313\u20131323","journal-title":"J Chem Inf Model"},{"key":"306_CR72","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1021\/jm061259g","volume":"50","author":"R Bergmann","year":"2007","unstructured":"Bergmann R, Linusson A, Zamora I (2007) SHOP: scaffold hopping by GRID-based similarity searches. J Med Chem 50:2708\u20132717","journal-title":"J Med Chem"},{"key":"306_CR73","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/jm000941m","volume":"43","author":"M Pastor","year":"2000","unstructured":"Pastor M, Cruciani G, McLay I, Pickett S, Clementi S (2000) Grid-independent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43:3233\u20133243","journal-title":"J Med Chem"},{"key":"306_CR74","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, De Boeck B, Ethirajulu K, Mackie C, Howe T, Vianello R (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48:6970\u20136979","journal-title":"J Med Chem"},{"key":"306_CR75","doi-asserted-by":"crossref","unstructured":"G. Cruciani (ed) Molecular Interaction Fields: Applications in drug discovery and ADME prediction, vol 27, Chapter 1. First published: 26 October 2005 Copyright \u00a9 2006 Wiley-VCH Verlag GmbH & Co. KGaA","DOI":"10.1002\/3527607676"},{"key":"306_CR76","unstructured":"G. van Rossum (1995) Python tutorial. Technical report CS-R9526, Centrum voor Wiskunde en Informatica (CWI), Amsterdam."},{"key":"306_CR77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/acs.jcim.5b00644","volume":"56","author":"A Heifetz","year":"2016","unstructured":"Heifetz A, Chudyk EI, Gleave L, Aldeghi M, Cherezov V, Fedorov DG, Biggin PC, Bodkin MJ (2016) The fragment molecular orbital method reveals new insight into the chemical nature of GPCR\u2212ligand interactions. J Chem Inf Model 56:159\u2013172","journal-title":"J Chem Inf Model"},{"key":"306_CR78","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/acs.jpca.6b00163","volume":"120","author":"DG Fedorov","year":"2016","unstructured":"Fedorov DG, Kitaura K (2016) Subsystem analysis for the fragment molecular orbital method and its application to protein\u2212ligand binding in solution. J Phys Chem A 120:2218\u20132231","journal-title":"J Phys Chem A"},{"key":"306_CR79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coph.2015.05.011","volume":"23","author":"J Sunshine","year":"2015","unstructured":"Sunshine J, Taube JM (2015) PD-1\/PD-L1 inhibitors. Curr Opin Pharmacol 23:32\u201338","journal-title":"Curr Opin Pharmacol"},{"issue":"18","key":"306_CR80","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1080\/07391102.2018.1563568","volume":"37","author":"X Sun","year":"2019","unstructured":"Sun X, Liang L, Gu J, Zhuo W, Yan X, Xie T, Wu Z, Liu X, Gou X, Liu W, He G, Gan Y, Chang S, Shi H, Hu J (2019) Inhibition of programmed cell death protein ligand-1 (PD-L1) by benzyl ether derivatives: analyses of conformational change, molecular recognition and binding free energy. J Biomol Struct Dyn 37(18):4801\u20134812","journal-title":"J Biomol Struct Dyn"},{"key":"306_CR81","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.str.2016.06.026","volume":"24","author":"R Pascolutti","year":"2016","unstructured":"Pascolutti R, Sun X, Kao J, Maute RL, Ring AM, Bowman GR, Kruse AC (2016) Structure and dynamics of PD-L1 and an ultra-high-affinity PD-1 receptor mutant. Structure 24:1719\u20131728","journal-title":"Structure"},{"key":"306_CR82","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bbagen.2017.11.022","volume":"1862","author":"D Shi","year":"2018","unstructured":"Shi D, Zhou S, Liu X, Zhao C, Liu H, Yao X (2018) Understanding the structural and energetic basis of PD-1 and monoclonal antibodies bound to PD-L1: a molecular modeling perspective. BBA General Subjects 1862:576\u2013588","journal-title":"BBA General Subjects"},{"key":"306_CR83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00337","author":"H Ding","year":"2019","unstructured":"Ding H, Liu H (2019) Mapping the binding hot spots on human programmed cell death 1 and its ligand with free-energy simulations. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.9b00337","journal-title":"J Chem Inf Model"},{"issue":"6","key":"306_CR84","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bmcl.2019.01.028","volume":"29","author":"E Perry","year":"2019","unstructured":"Perry E, Mills JJ, Zhao B, Wang F, Sun Q, Christov PP, Tarr JC, Rietz TA, Olejniczak ET, Lee T, Fesik S (2019) Fragment-based screening of programmed death ligand 1 (PD-L1). Bioorg Med Chem Lett 29(6):786\u2013790","journal-title":"Bioorg Med Chem Lett"},{"key":"306_CR85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmgm.2019.06.001","volume":"91","author":"C Mej\u00edas","year":"2019","unstructured":"Mej\u00edas C, Guirola O (2019) Pharmacophore model of immunocheckpoint protein PD-L1 by cosolvent molecular dynamics simulations. J Mol Graphics Modell 91:105\u2013111","journal-title":"J Mol Graphics Modell"},{"key":"306_CR86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10822-008-9239-y","volume":"23","author":"S Eyrisch","year":"2009","unstructured":"Eyrisch S, Helms V (2009) What induces pocket openings on protein surface patches involved in protein\u2013protein interactions? J Comput Aid Mol Des 23:73\u201386","journal-title":"J Comput Aid Mol Des"},{"key":"306_CR87","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.bmcl.2014.03.095","volume":"24","author":"W Guo","year":"2014","unstructured":"Guo W, Wisniewski JA, Ji H (2014) Hot spot-based design of small-molecule inhibitors for protein\u2013protein interactions. Bioorg Med Chem Lett 24:2546\u20132554","journal-title":"Bioorg Med Chem Lett"},{"key":"306_CR88","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ci200322s","volume":"52","author":"A Metz","year":"2011","unstructured":"Metz A, Pfleger C, Kopitz H, Pfeiffer-Marek S, Baringhaus K, Gohlke H (2011) Hot spots and transient pockets: predicting the determinants of small-molecule binding to a protein-protein interface. J Chem Inf Model 52:120\u2013133","journal-title":"J Chem Inf Model"},{"key":"306_CR89","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.accounts.5b00516","volume":"49","author":"A Stank","year":"2016","unstructured":"Stank A, Kokh DB, Fuller JC, Wade RC (2016) Protein binding pocket dynamics. Acc Chem Res 49:809\u2013815","journal-title":"Acc Chem Res"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00306-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-020-00306-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00306-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T07:55:36Z","timestamp":1722585336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-020-00306-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["306"],"URL":"https:\/\/doi.org\/10.1007\/s10822-020-00306-0","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}